Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma

Japanese Journal of Clinical Oncology

Volumn 43, Issue 7, 2013, Pages 740-746

  Fukushima, Hiroshi ^a   Masuda, Hitoshi ^a   Yokoyama, Minato ^a   Tatokoro, Manabu ^a   Yoshida, Soichiro ^a   Ishioka, Junichiro ^a   Matsuoka, Yoh ^a   Numao, Noboru ^a   Koga, Fumitaka ^a   Saito, Kazutaka ^a   Fujii, Yasuhisa ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Obesity; Recurrence; Renal cell carcinoma

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PROGNOSIS; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY;

DIABETES MELLITUS; OBESITY; RECURRENCE; RENAL CELL CARCINOMA;

ADULT; AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; CARCINOMA, RENAL CELL; DIABETES COMPLICATIONS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; OBESITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880157007     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt070     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003;30:843-52.
3. Federation ID. Fifth edition of Diabetes Atlas; 2011-[cited 2012 Nov 3] http://www.eatlas.idf.org.
4. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83.
5. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-87.
6. Ronco AL, De Stefani E, Deneo-Pellegrini H, Quarneti A. Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev 2012;13:139-46.
7. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, et al. Case- control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000;11:707-11.
8. Schlehofer B, Pommer W, Mellemgaard A, et al. International renal-cell-cancer study. VI. The role of medical and family history. Int J Cancer 1996;66:723-6.
9. Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010;7:277-85.
10. Vavallo A, Lucarelli G, Tedeschi M, et al. Diabetes mellitus is a risk factor for recurrence and mortality in patients with renal cell carcinoma. Eur Urol Suppl 2011;10:139-40.
11. Antonelli A, Arrighi N, Corti S, et al. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. Urol Oncol Epub 2012. doi:10.1016/ j.urolonc.2011.12.013.
12. Lee S, Hong SK, Kwak C, Kim HH, Lee SE. Prognostic significance of diabetes mellitus in localized renal cell carcinoma. Jpn J Clin Oncol 2012;42:318-24.
13. Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013;132:625-34.
14. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208-25.
15. Fukushima H, Masuda H, Kawakami S, et al. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology 2012;79:1329-34.
16. Jayachandran J, Aronson WJ, Terris MK, et al. Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev 2010;19:9-17.
17. Moreira DM, Anderson T, Gerber L, et al. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes Control 2011;22:977-83.
18. Wu C, Moreira DM, Gerber L, Rittmaster RS, Andriole GL, Freedland SJ. Diabetes and prostate cancer risk in the REDUCE trial. Prostate Cancer Prostatic Dis 2011;14:326-31.
19. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th edn. New York: Springer 2009.
20. Medeiros LJ, Jones EC, Aizawa S, et al. Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:990-1.
21. World Health Organization WPR, International Association for the Study of Obesity. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications Australia Pty Limited 2000.
22. Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN, Jr. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 1994;60:23-8.
23. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006;17:328-36.
24. Duman BS, Turkoglu C, Gunay D, Cagatay P, Demiroglu C, Buyukdevrim AS. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity. Diabetes Nutr Metab 2003;16:243-50.
25. Rosendahl A, Forsberg G. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines. Int J Oncol 2004;25:1327-36.
26. Rosendahl AH, Holly JM, Celander M, Forsberg G. Systemic IGF-I administration stimulates the in vivo growth of early, but not advanced, renal cell carcinoma. Int J Cancer 2008;123:1286-91.
27. Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML. Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma. J Urol 2003;170:420-4.
28. Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev 2009;25:705-16.